Allena Pharmaceuticals, Inc.
Developing Therapeutics for Patients with Rare and Severe Metabolic and Kidney Disorders
13 employees · est. 2011 · Newton, United States
Bilayer Therapeutics
Developing innovative treatments for GI disease and metabolic disorders (obesity & diabetes) based on GLP-1 and TGR5
1 employees · est. 2020 · Cambridge, United States
Allena Pharmaceuticals, Inc. is the older company (2011 vs 2020); Allena Pharmaceuticals, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Allena Pharmaceuticals, Inc. | Bilayer Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2011 older | 2020 |
| Headquarters | ||
| Headquarters | Newton, United States | Cambridge, United States |
| Employees | ||
| Employees | 13 larger | 1 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Pharmaceutical | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Series Unknown |
| Total Funding | ||
| Total Funding | $198.80M | $2.00M |
| Funding Rounds | ||
| Funding Rounds | 8 | 1 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical Company, Oral Enzyme Therapeutics, Metabolic Disorders, Kidney Disorders, Rare Diseases, Renal Disease, Clinical Trials, Enzyme Technology, GI Tract, Oxalate Reduction, Urate Reduction, Chronic Kidney Disease, Phase 3 Clinical Program, Enteric Hyperoxaluria, Drug Development | GI Disease, Metabolic Disorders, Obesity, Diabetes, GLP-1, TGR5, Bilayer Tablet Technology, Drug Development, Bile Acid, Motility Disorders, Chronic Constipation, Innovative Treatments, First-in-class Treatments, Drug Candidate |
| Website | ||
| Website | allenapharma.com | bilayer-therapeutics.com |
About Allena Pharmaceuticals, Inc.
Allena Pharmaceuticals, Inc. is a biotechnology and pharmaceutical startup that focuses on developing therapeutics for patients suffering from rare and severe metabolic and kidney disorders. Founded in 2011 and headquartered in the United States, the company's mission is to address metabolic disorde...
About Bilayer Therapeutics
Bilayer Therapeutics is a development-stage company focused on pioneering treatments for gastrointestinal (GI) disease and metabolic disorders such as obesity and diabetes. The company's approach utilizes GLP-1 and TGR5 - regulatory mechanisms for metabolism and motility. Founded in 2020 by a team o...
We will tell you when either one moves
BounceWatch watches Allena Pharmaceuticals, Inc. and Bilayer Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Allena Pharmaceuticals... and Bilayer Therapeutics — by email.
Frequently Asked Questions
Compare Allena Pharmaceuticals, Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Allena Pharmaceuticals, Inc. on 12 Sep 2024, and Bilayer Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
